PerturbAI and OpenAI Launch AI Reasoning Agents for Biomedical Discovery - Genetic Engineering and Biotechnology News

PerturbAI and OpenAI are developing AI agents to accelerate biomedical research and drug discovery. This could lead to faster medical breakthroughs that eventually benefit patients and healthcare professionals.